SEC Form 4 Latest Filings for Acumen Pharmaceuticals, Inc. (Nasdaq: ABOS)

SEC Form 4 details and latest filings of insiders (officer, director, 10% stockholder, and anyone who possesses inside information) buying and selling Acumen Pharmaceuticals, Inc. (ABOS) stocks, listed on Nasdaq, within the last 150 days.